Clinical trial
The CLEVER Study - Coreg And Left Ventricular Mass Regression
NCT00108082 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00108082 |
|---|---|
| Title | The CLEVER Study - Coreg And Left Ventricular Mass Regression |
| Official title | A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertrophy, Left Ventricular |
| Intervention type | Drug |
| Interventions | carvedilol MR, atenolol, lisinopril |
| Enrollment | 287 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Apr 14, 2005 |
| Last update posted | Dec 16, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: